Tech Company Financing Transactions
Wyndly Funding Round
Wyndly, operating out of New York, received $2 million from Civilization Ventures, Goodwater Capital and private investors.
Transaction Overview
Company Name
Announced On
2/9/2023
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the funds to bring at-home allergy testing to everyone.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
169 Madison Ave #2137
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Website
Email Address
Overview
Wyndly gives people with allergies lifelong relief. We ship you personalized oral allergy drops that train your immune system to beat your personal allergy triggers. With unlimited doctor access and completely at-home care, we've made allergy care convenient.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Aakash Shah
Chief Medical Officer
Manan Shah
Browse more venture capital transactions:
Prev: 2/9/2023: Rebellyous Foods venture capital transaction
Next: 2/9/2023: Mino Games venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs